The experience of using omalizumab biosimilar in patients with atopic bronchial asthma and clinically significant sensitization to aeroallergens in the Republic of Uzbekistan
: - 2-, - 2-, - ; - -( R01AD), - ; : - 100/6 ; : - 200/6 ( ) MART - * 6-11 / #
Authors
- Shukhrat Ziyadullaev (ORCID: https://orcid.org/0000-0002-9309-3933)
- Tamara Aripova (ORCID: https://orcid.org/0000-0001-9783-9600)
- Venera Baybekova
- Kamalov Zaynitdin Sayfutdinovich (ORCID: https://orcid.org/0000-0001-6551-3155)
- Nazifa D. Dustbabaeva (ORCID: https://orcid.org/0000-0001-6987-7749)
- N.P. Aydarova (ORCID: https://orcid.org/0000-0002-6160-708X)
Publication Details
- Journal
- Immunologiya
- Published
- 2025-01-01
- DOI
- https://doi.org/10.33029/1816-2134-2025-46-2-182-193
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00